Some of the most exciting new drugs are being discovered by mid-sized pharma and biotech ... analysed a group of 35 mid-cap companies, most of which are based in the US, but does include European ...

Reliance Infrastructure, Afcons and Narayana Hrudayalaya will be among 202 companies to post earnings reports for the January ...

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalData. BMS had the ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...

Figure 1: Top 20 global biopharmaceutical companies, by market cap, as of 31 March 2025 Source: GlobalData, Pharma Intelligence Center; Stock Exchanges; Annual Reports. Vertex Pharmaceuticals ...

Based in Denmark ... Novo Nordisk has a market presence in around 170 countries. It's one of the biggest companies in Europe, and at one point, its market cap surpassed Denmark's gross domestic ...

Deven Choksey suggests a protective portfolio strategy, favoring large-cap companies amidst market enthusiasm for mid and ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC (“RP Management”). The acquisition received overwhelming ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, the bloc would fall further behind the U.S., where tariff threats have ...